Will Quantum Computing Inc. (QUBT) Stock Keep Its Losing Streak Going in 2026?

Quantum Computing Inc. (NASDAQ: QUBT) agreed to acquire Luminar Semiconductor in an all-cash $110 million deal (the Luminar parent filed Chapter 11 but the semiconductor unit is not a debtor), with closing expected roughly a year out and contingent on bankruptcy-court approval. QCi, a quantum photonics hardware developer with several patents, reported $484,000 of revenue versus $29 million of operating expenses through the first nine months of 2025, has more than 224 million shares outstanding and a market cap above $2.7 billion after significant dilution, and its stock is down over 30% in the past 12 months; the transaction could add revenue-generating hardware but execution, financing and dilution risks remain material.

Analysis

Market structure: The QUBT→Luminar Semiconductor deal shifts a nascent photonics supply chain toward consolidation; direct beneficiaries are QUBT (access to customers/IP) and LuminarSem customers (continuity), while LAZR equity and unsecured creditors face downside in Chapter 11. Pricing power remains limited because photonic quantum hardware is early-stage — expect revenue contributions to be modest in the first 12–24 months, so valuation re-rating will be sentiment-driven, not fundamentals-driven.

Risk assessment: Key tail risks are court rejection of the sale or discovery of IP encumbrances (low-probability, high-impact), continued equity dilution (shares quadrupled over 3 years), and integration failure; expect immediate volatility (days–weeks), binary court/filing catalysts in 3–12 months, and revenue realization or failure over 12–36 months. Hidden dependencies include transferability of Luminar Semiconductor contracts and supplier constraints for photonic chips which could delay revenue recognition by 6–18 months.

Trade implications: For tactical exposure use defined-risk options (asymmetric long via LEAP call spreads sized 0.5–1.0% of portfolio) to capture upside if the deal closes within ~12 months; for downside, buy 3–6 month puts or short LAZR equity (0.5–1.0%) to play bankruptcy risk. Reallocate 2–3% from speculative small-cap quantum names into high-quality large-cap semis (e.g., NVDA or SMH) as a sector-rotation hedge against continued dilution-driven drawdowns.

Contrarian angles: The market likely underprices LuminarSem's customer revenue in the near term — a successful integration could drive 30–50% re-rating from current depressed sentiment, but the more probable mispricing is on the downside from further dilution. Historical parallels (small-cap semiconductor tuck-ins) show value unlocked only after 12–24 months of execution; therefore, patience and event-driven trigger discipline are critical.

Key Decisions for Investors

• Establish a 0.5%–1.0% portfolio position long QUBT via a 9–12 month call spread (buy LEAP ~40–60% OTM, sell a higher strike to fund ~50% of premium) only if QUBT shares drop ≥20% from today; target >2x payoff if acquisition is approved within 12 months, cap loss to premium paid.
• Open a 0.5%–1.0% short position in LAZR equity (or equivalent put exposure) to capture bankruptcy downside over the next 3–9 months; tighten or exit if court filings show sale proceeds sufficient to fully repay unsecured claims.
• If holding QUBT equity >1% of portfolio, buy 3–6 month ATM puts equal to 50% of position size as protection against deal failure or accelerated dilution; reduce equity hold to ≤0.25% if quarterly cash burn >$10M or shares outstanding increase >10% within a 3-month window.
• Rotate 2%–3% of speculative small-cap quantum exposure into large-cap semiconductors (e.g., NVDA or SMH) over the next 30 days to hedge market-sentiment risk while preserving upside to industry growth; review after 3 and 12 months around court and integration milestones.